Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Current Assets (2016 - 2025)

Surgery Partners' Current Assets history spans 12 years, with the latest figure at $1.2 billion for Q4 2025.

  • For Q4 2025, Current Assets rose 2.8% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, up 2.8%, while the annual FY2025 figure was $1.2 billion, 2.8% up from the prior year.
  • Current Assets for Q4 2025 was $1.2 billion at Surgery Partners, up from $1.1 billion in the prior quarter.
  • Across five years, Current Assets topped out at $1.2 billion in Q4 2025 and bottomed at $738.3 million in Q3 2022.
  • The 5-year median for Current Assets is $941.6 million (2021), against an average of $954.5 million.
  • The largest annual shift saw Current Assets surged 65.6% in 2021 before it fell 17.26% in 2022.
  • A 5-year view of Current Assets shows it stood at $946.1 million in 2021, then decreased by 2.65% to $921.0 million in 2022, then fell by 2.82% to $895.0 million in 2023, then increased by 25.07% to $1.1 billion in 2024, then grew by 2.8% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Current Assets are $1.2 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025).